HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Interferon lambda-3 polymorphism and response to pegylated interferon in patients with hepatitis D.

AbstractBACKGROUND:
Specific single nucleotide polymorphisms (SNPs) near the interferon lambda-3 (IFNλ3) gene (formerly interleukin 28B) influence the response to treatment with interferon in hepatitis C patients. We aimed to investigate such an influence in hepatitis D patients.
METHODS:
The study population consisted of hepatitis D patients who were previously treated with pegylated interferon for one year and who were spontaneous clearers of the virus post recent superinfection. The SNP of IFNλ3, rs12979860, was determined by polymerase chain reaction-restriction fragment length polymorphism protocol.
RESULTS:
The total number of patients was 64; median age was 30.5 years and 53 were male. The number of patients with sustained virological response 1 year post-treatment was 17, non-responders 29, relapsers 11 and spontaneous clearers post superinfection 7. Cirrhosis was present in 28 (44%). IFNλ3, rs12979860 genotype CC, was present in 41 (64.1%), CT in 21 (32.8%) and TT in 2 (3.1%). There was no difference in the body mass index, baseline alanine aminotransferase, hepatitis B e antigen and HBV DNA status among patients with sustained response and response failure (no response or relapse). The median age of response failures was 33.5 years compared to 26 in responders (P=0.024). They had higher gamma glutamyl transferase levels (P=0.030) and cirrhosis (P=0.003). Genotype CC was present in 29/40 of response failures compared to 9/17 of the responders (P=0.152). Logistic regression analysis showed that cirrhosis was the independent risk factor for failure to have a response (P=0.001). 4/7 patients with spontaneous clearance had genotype CC.
CONCLUSIONS:
IFNλ3 rs12979860 SNP does not have any significant influence on long-term hepatitis D clearance. Presence of cirrhosis may influence the response.
AuthorsZaigham Abbas, Javed Yakoob, Muhammad A Umer, Minaam Abbas, Saeed Hamid
JournalAntiviral therapy (Antivir Ther) Vol. 20 Issue 5 Pg. 529-33 ( 2015) ISSN: 2040-2058 [Electronic] England
PMID25668821 (Publication Type: Journal Article)
Chemical References
  • Antiviral Agents
  • IFNL3 protein, human
  • Interferon-alpha
  • Interleukins
  • RNA, Viral
  • Recombinant Proteins
  • Polyethylene Glycols
  • Interferons
  • gamma-Glutamyltransferase
  • Alanine Transaminase
  • peginterferon alfa-2a
Topics
  • Adolescent
  • Adult
  • Alanine Transaminase (blood)
  • Antiviral Agents (therapeutic use)
  • Female
  • Hepatitis C, Chronic (drug therapy)
  • Hepatitis D, Chronic (drug therapy)
  • Hepatitis Delta Virus (drug effects)
  • Humans
  • Interferon-alpha (therapeutic use)
  • Interferons
  • Interleukins (genetics)
  • Liver (pathology, virology)
  • Liver Cirrhosis (pathology, virology)
  • Male
  • Middle Aged
  • Polyethylene Glycols (therapeutic use)
  • Polymorphism, Restriction Fragment Length
  • Polymorphism, Single Nucleotide
  • RNA, Viral (blood)
  • Recombinant Proteins (therapeutic use)
  • Treatment Outcome
  • Young Adult
  • gamma-Glutamyltransferase (blood)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: